Intrafamilial transmission of hepatitis C infection in egyptian multitransfused thalassemia patients

Journal of Tropical Pediatrics

Volumn 59, Issue 4, 2013, Pages 309-313

  Said, Fadwa ^a   Beshlawy, Amal El ^a   Hamdy, Mona ^a   Raziky, Mona El ^a   Sherif, Mai ^a   Kader, Ahmed Abdel ^a   Ragab, Lamis ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Egypt; Hepatitis C; Intrafamilial; Multitransfused; Thalassemia

Indexed keywords

VIRUS ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; DISEASE TRANSMISSION; EGYPT; ENZYME IMMUNOASSAY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREVALENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; THALASSEMIA; VIRUS LOAD;

EGYPT; HEPATITIS C; INTRAFAMILIAL; MULTITRANSFUSED; THALASSEMIA;

ADOLESCENT; ADULT; BLOOD TRANSFUSION; CHILD; CONTACT TRACING; EGYPT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAMILY; FAMILY HEALTH; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MIDDLE AGED; PREVALENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, VIRAL; THALASSEMIA; VIRAL LOAD; YOUNG ADULT;

EID: 84881516763     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fmt017     Document Type: Article

References (39)

1. Strickland GT, Hefni H, Salman T, et al. Role of Hepatitis C infection in chronic liver disease in Egypt. Am J Trop Med Hyg 2002;67:436-42.
2. Esteban JI, Genesca J, Alter HJ. Hepatitis C molecular biology, pathogenesis, epidemiology, clinical features and prevention. In: Boyer JL, and Ockn RK (eds). Progress in liver disease. Philadelphia: W.B.saunders, 1992, 253-82.
3. El Gohary A, Hassan A, Nooman Z, et al. High prevalence of hepatitis C virus among urban and rural population groups in Egypt. Acta Tropica 1995;59:155-61.
4. Kaddah N, Mustafa A, Abd el Raouf E, et al. Recent insight about anti hepatitis C antibodies in pediatric thalassemia major and sickle cell anemia. J Pediatr 2006;20:115-19.
5. Ragab L, Helal S, Zaghloul N, et al. Clinicovirologic analysis of hepatitis C infection in transfusion-dependent beta-thalassemia major children. Int J Lab Hematol 2010;32:184-190.
6. Ackerman Z, Ackerman E, Paltiel O. Intrafamilial transmission of hepatitis C virus: a systematic review. J Viral Hepat 2000;7:93-103.
7. Fiore MD, Mitchell JE, Doan T, et al. The Abbot IMX automated brnchtop immunochemistry analyzer system. Clin Chem 1988;34:1726-32.
8. Yang JH, Lai JP, Douglas SD, et al. Real time RT-PCR for quantitation of hepatitis C virus RNA. J Virol Methods 2002;102:119-28.
9. Pawlotsky JM. Hepatitis C virus genetic variability: pathogenic and clinical implications. Clin Liver Dis 2003;7:45-66.
10. Abu El Hassan AM, El Beshlawy A, Kaddah N, et al. The frequency of blood born viruses esp (HBV, HCV and HIV) among Egyptian thalassemic children. New Egypt J Med 1993;8:135-8.
11. Zaki ES, Gorg L, Chowdhury R, et al. Prevalence of hepatitis D in patients infected with hepatitis B. J Trop Pediatr 2003;49:371-4.
12. Omar N, Salama K, Adolf S, et al. Major risk of blood transfusion in hemolytic anemia patients. Blood Coagul Fibrinolysis 2011;4:280-4.
13. Sibal A, Mishra D, Arora M. Hepatitis C in childhood. J Indian Med Assoc 2002;100:93-8.
14. Choudhury N, Saraswat S, Naveed M. Serological monitoring of thalassemia major patients for transfusion associated viral infections. Indian J Med Res 1998; 107:263-8.
15. Akhtar S, Moatter T, Azam SI. Prevalance and risk factors for intra-familial transmission of HCV in Karachi, Pakistan. J Virol Hepat 2002;9:309-14.
16. De-Montalembert M, Costagliola DG, Lefrere JJ, et al. Prevalence of markers for human immunodeficiency virus types 1 and 2, human T-lymphotropic virus type I, cytomegalovirus, and hepatitis B and C virus in multiply transfused thalassemia patients. The French Study Group on Thalassemia. Transfusion 1992;32: 509-12.
17. Jamal R, Fadzillah G, Zulkifli SZ, et al. Seroprevalence of hepatitis B, hepatitis C, CMV and HIV in multiply transfused thalassemia patients: results from a thalassemia day care center in Malaysia. Southeast Asian J Trop Med Public Health 1998;29:792-4.
18. Alter MJ. HCV infection in USA. J Hepatol 1999;3: 88-91.
19. Nierengarten MB. Risk of transfusion transmitted virus continues to decline in developed countries. Transfusion 2002;42:966-98.
20. Medhat A, Shehata M, Laurence S, et al. Hepatitis C in a community in upper Egypt: Risk factors for infection: Hepatitis C prevention project, Assiut University, Faculty of Medicine, Egypt. Am J Trop Med Hyg 2002;66:628-33.
21. Garrido Serrano A, Guerrero Igea FJ, Lepe Jimenez JA, et al. Hepatitis C virus infection, increased serum ferritin and hyperinsulinemia. Rev Esp Enferm Dig 2001;93:639-48.
22. Al Shayyab M, Baticha A, El Khateeb M. The prevalence of hepatitis B, hepatitis C and human immunodeficiency virus markers in multitransfusion patients. J Trop Pediatr 2001;47:239-42.
23. El Banna H, Bakr A, Naira A. HCV infection among hemodialysis patients. Risk factors and predominant genotype. Minoufiya. Medical J 2001;14:9-11.
24. Habib M, Mohamed MK, Abdel Aziz F, et al. Hepatitis C virus infection in a community in the Nile Delta: risk factors for seropositivity. Hepatology 2001;33:248-53.
25. Neal KR, Jones DA, Killy D, et al. Risk factors for hepatitis C virus infection. A case-control study of blood donors in the Trent Region (UK). Epidemiol Infect 1994;12:595-601.
26. Al-Nasser MN. Intrfamilial transmission of hepatitis C virus (HCV): a major mode of spread in the Saudi Arabia population. Ann Trop Pediatr 1992;12: 211-5.
27. Napoli N, Fiore G, Vella F, et al. Prevalence of antibodies to hepatitis C virus among family members of patients with chronic hepatitis C. Euro J Epidemiol 1993;9:629-32.
28. Pasha O, Luby SP, Khan AJ, et al. Household members of hepatitis C virus infected people in Haizabad, Pakistan: infections by injections from health care providers. Epidemiol Infec 1999;123:515-8.
29. Fani A, Sofian M, Fathollahi M, et al. Intra familial transmission of hepatitis C virus infection in Iran. Iranian Journal of Clinical Infectious Diseases 2009;4: 157-61.
30. Hajiani E, Masjedizadeh R, Hashemi J, et al. Hepatitis C virus transmission and its risk factors within families of patients infected with hepatitis C virus in southern Iran: Khuzestan. World J Gastroenterol 2006;12: 7025-8.
31. Del Corno G, Civardi E. Intrafamilial transmission of hepatitis B and C viruses in an Italian local health district. Ann Ig 2006;18:287-95.
32. Kim YS, Chi HS, Ahn YO, et al. Lack of familial clustering of hepatitis C virus infection. Int J Epidemiol 1998;27:525-9.
33. Mohamed MK, Magder LS, Abdel-Hamid M, et al. Transmission of hepatitis C virus between parents and children. Am J Trop Med Hyg 2006;75:16-20.
34. Mohamed MK, Abdel-Hamid M, Mikhail NN, et al. Intrafamilial transmission of hepatitis C in Egypt. Hepatol 2005;42:683-7.
35. Luby SP, Qamruddin K, Shah AA, et al. The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan. Epidemiol Infect 1997;119:349-56.
36. Oritz-Movilla N, Lazaro P, Rodruiz-Indigo. HCV replicating in sweat gland and is released in sweat in patients with chronic HCV infection. J Med Introl 2002;68:526-36.
37. McOmish F, Yap PL, Dow BC, et al. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol 1994;32:884-92.
38. Chamberlain RW, Adams N, Saeed AA, et al. Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East. J Gen Virol 1997;78:1341-7.
39. Alvarez-Munor MT, Vences-Avites MA, Damacro L. HCV-RNA in blood donors and family members. Arch Med Res 2001;32:442-5.